The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key territories has introduced significant uncertainty . Investors are now assessing the effect of riva